Organization · Venture Capital
Curewell Capital
Curewell Capital is a growth-oriented investment firm based in Los Angeles, California, focused on building industry-leading healthcare companies. They invest across various healthcare sectors, partnering with management teams to enhance patient outcomes and foster innovation.
Overview
What Curewell Capital does
What Curewell Capital is
Curewell Capital is a growth-oriented investment firm based in Los Angeles, California, focused on building industry-leading healthcare companies. They invest across various healthcare sectors, partnering with management teams to enhance patient outcomes and foster innovation.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find Curewell Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Curewell Capital as a funder
Investment thesis
Curewell Capital is a growth-oriented investment firm focused on building industry-leading healthcare companies by partnering with owners and management teams to improve patient outcomes and foster innovation.
Focus narrative
Curewell Capital invests across various sectors within healthcare, including healthcare services, pharmaceutical services, medical devices, and healthcare technology. The firm targets essential businesses with strong growth potential and defensive characteristics, emphasizing innovation and operational excellence.
Value beyond capital
Curewell Capital adds value to its portfolio companies through strategic partnerships, operational improvements, and a proprietary growth framework known as GRO™. The firm focuses on enhancing efficiencies and driving innovation to improve patient outcomes.
Focus and fit
- Stages
- Growth Equity
- Sectors
- Healthcare · Pharma Tech · Medical Devices
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Curewell Capital's notable portfolio companies include: Wilmington PharmaTech: A specialty contract research and manufacturing organization focused on complex small molecule APIs. WeInfuse: A technology provider for infusion therapy, serving over 1,000 infusion centers across the U.S. AMR Clinical: An integrated research site management organization with extensive experience in executing clinical trials.
Common questions
What to know about Curewell Capital
Upseed classifies Curewell Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.